Bone pain (also known medically by several other names) is pain coming from a bone. It occurs as a result of a wide range of diseases and/or physical conditions and may severely impair the quality of life.
Bone pain belongs to the class of deep somatic pain, often experienced as a dull pain that cannot be localized accurately by the patient. This is in contrast with the pain which is mediated by superficial receptors in, e.g., the skin. Bone pain can have several possible causes ranging from extensive physical stress to serious diseases such as cancer.
For many years[when?] it has been known that bones are innervated with sensory neurons. Yet their exact anatomy remained obscure due to the contrasting physical properties of bone and neural tissue. More recently,[when?] it is becoming clear what types of nerves innervated which sections of bone. The periosteal layer of bone tissue is highly pain-sensitive and an important cause of pain in several disease conditions causing bone pain, like fractures, osteoarthritis, etc. However, in certain diseases the endosteal and haversian nerve supply seems to play an important role, e.g. in osteomalacia, osteonecrosis, and other bone diseases. Thus there are several types of bone pain, each with many potential sources or origins of cause.
A number of diseases can cause bone pain, including the following:
- Endocrine, such as hyperparathyroidism, osteoporosis, kidney failure.
- Gastrointestinal or systemic, such as celiac disease and non-celiac gluten sensitivity (both often occur without obvious digestive symptoms), inflammatory bowel disease (including Crohn's disease and ulcerative colitis).
- Hematologic, such as Cushing's syndrome, histiocytosis, multiple myeloma and sickle cell anaemia.
- Infectious, such as Lyme disease and osteomyelitis.
- Neurological, such as spinal cord injury and vertebral degeneration.
- Oncologic, such as bone metastasis and leukemia.
- Rheumatic, such as ankylosing spondylitis, rheumatoid arthritis, gout.
- Others, such as fractures, osteoarthritis, Paget's disease of bone (also termed osteitis deformans or ambiguously, just Paget's disease).
Causes in children
- Acute leukemia.
- Acute rheumatic fever, a very dangerous disease that can cause permanent cardiac damage.
- Untreated celiac disease, which can present without gastrointestinal symptoms.
- Fibromyalgia, which affects people of all ages.
- Growing pains.
- Hypermobility syndrome can present with knee or ankle pain.
- Henoch–Schönlein purpura.
- Fibrous dysplasia of bone.
- Injury such as a fracture.
- Inflammatory bowel disease.
- Juvenile idiopathic arthritis.
- Legg–Calvé–Perthes disease.
- Lyme disease, which is transmitted by ticks and is characterized by debilitating polyarthritis, neurologic symptoms, and erythema migrans.
- Osteomalacia/rickets in adolescents.
- Septic arthritis, a severe infection of the joint that can lead to permanent joint damage.
- Viral diseases, including the measles, influenza, mononucleosis, chickenpox, and mumps.
Pain caused by cancer within bones is one of the most serious forms of pain. Because of its severity and uniqueness with respect to other forms of pain, it is extensively researched. According to studies of bone cancer in mouse femur models, it has been determined that bone pain related to cancer occurs as a result of destruction of bone tissue. Chemical changes that occur within the spinal cord as a result of bone destruction give further insight into the mechanism of bone pain.
Metastatic cancer cells often establish themselves within the skeleton. When the cancer cells have metastasized, the mechanical dynamics of the bone matrix become weaker as skeletal strength decreases. This leads to several other complications throughout the body including pain, thus decreasing the patient’s quality of life.
Bone tumors are composed of a conglomeration of cell types including cancer and immune system cells. Often tumor cells secrete growth factors which activate receptors close to primary afferent neurons. Activation of these neural receptors is a contributing factor to pain sensation. Additionally, inflammatory lipids called prostaglandins, which are produced at high rates by cancer cells within tumors, activate nociceptors when they bind together.
Stimulation of specialized pain-sensitive nerve fibers (nociceptors) that innervate bone tissue leads to the sensation of bone pain. Bone pain originates from both the periosteum and the bone marrow which relay nociceptive signals to the brain creating the sensation of pain. Bone tissue is innervated by both myelinated (A beta and A delta fiber) and unmyelinated (C fiber) sensory neurons. In combination, they can provide an initial burst of pain, initiated by the faster myelinated fibers, followed by a slower and longer-lasting dull pain initiated by unmyelinated fibers.
Nociceptors responsible for bone pain can be activated via several mechanisms including deterioration of surrounding tissue, bone destruction, and physical stress which shears the bone, vascular, muscle, and nervous tissue.
Another commonly used method for treating bone pain is radiotherapy, which can be safely administered in low doses. Radiotherapy utilizes radioactive isotopes and other atomic particles to damage the DNA in cells, thus leading to cell death. By targeting cancer tumors, radiotherapy can lead to decrease in tumor size and even tumor destruction. A form of radiotherapy that is often used in cases of bone cancer is systemic radioisotope therapy, where the radioisotopes target sections of the bone specifically undergoing metastasis.
In the case of bone fractures, surgical treatment is generally the most effective. Analgesics can be used in conjunction with surgery to help ease pain of damaged bone.
Mouse and other animal models are being heavily used to determine the neuron tissue densities in bone and mechanisms for maintenance of bone pain. This information is pertinent to determining the biological and physiological components of pain in the bone. By creating a detailed map relating the types of nerves going through the different sections of bone, it is possible to pin-point locations in the bone that are at a higher risk of being susceptible to bone pain.
Treatments focusing on biological components such as cannabinoid receptors are being tested for effectiveness. Through testing in mouse models, it has been shown that activation of the CB-1 receptor helps reduce reactions associated with acute pain, indicating that it alleviates bone pain. Thus, a new target for potential treatments is activation of the CB-1 receptor.
Modern research and techniques are attempting to provide longer-lasting and more effective methods of treating bone pain by developing and applying new physiological knowledge of nervous tissue within the bone. If thorough understanding of the intra-neuronal mechanisms relating to pain can be developed, then new and more effective treatment options can be created and tested. Thus, it is critical to fully understand the mechanism which dictates bone pain.
Bone pain is also known by the following names:
|ostalgia||//||ost- + -algia|
|ostealgia||//||oste- + -algia|
|osteodynia||//||osteo- + -dynia|
- Luger, N. Mach, D. Sevcik, M. Mantyh, P. (2005). Bone cancer pain: From mechanism to model to therapy. Journal of Pain and Symptom Management. 29(5): 32-46.
- Zwas, T. Elkanovitch, R. George, F. (1987). Interpretation and Classification of Bone Scintigraphic Findings in Stress Fractures. Journal of Nuclear Medicine. 28: 452-457.
- Mantyh, P. Clohisy, D. Koltzenburg, M. Hunt, S. (2002). Molecular Mechanism of Cancer Pain. Nature Reviews Cancer. 2: 201-209.
- McCredie J (2007). Nerves in bone: the silent partners. Skeletal Radiology. 36: 473–475.
- Mach, D. Rogers, S. Sabino, M. Luger, N. Schwei, M. Pomonis, J. Keyser, C. Clohisy, D. Adams, D. O’leary, P. Mantyh, P. (2002). Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur. Neuroscience. 113(1):155-166.
- Falk S, Uldall M, Heegaard AM. (2012). The role of purinergic receptors in cancer-induced bone pain. J Osteoporos. 2012;2012:758181. doi: 10.1155/2012/758181
- Mantyh PW (2014). "The neurobiology of skeletal pain". Eur J Neurosci (Review). 39 (3): 508–19. doi:10.1111/ejn.12462. PMC 4453827. PMID 24494689.
- Leffler DA, Green PH, Fasano A (Oct 2015). "Extraintestinal manifestations of coeliac disease". Nat Rev Gastroenterol Hepatol (Review). 12 (10): 561–71. doi:10.1038/nrgastro.2015.131. PMID 26260366. S2CID 15561525.
- Aziz I, Hadjivassiliou M, Sanders DS (Sep 2015). "The spectrum of noncoeliac gluten sensitivity". Nat Rev Gastroenterol Hepatol (Review). 12 (9): 516–26. doi:10.1038/nrgastro.2015.107. PMID 26122473. S2CID 2867448.
- Junnila JL, Cartwright VW (2006). "Chronic musculoskeletal pain in children: part II. Rheumatic causes". Am Fam Physician. 74 (2): 293–300. PMID 16883927.
- Buskila D, Ablin J (2012). "Pediatric fibromyalgia". Reumatismo (Review). 64 (4): 230–7. doi:10.4081/reumatismo.2012.230. PMID 23024967.
- Uziel Y, Hashkes PJ (2007). "Growing pains in children". Pediatric Rheumatology Online Journal. 5: 5. doi:10.1186/1546-0096-5-5. PMC 1869025. PMID 17550631.
- Junnila JL, Cartwright VW (2006). "Chronic musculoskeletal pain in children: part I. Initial evaluation". Am Fam Physician (Review). 74 (1): 115–22. PMID 16848385.
- Ajdinovic B, Jaukovic L, Antoniou D (2013). "Five benign myoskeletal diseases in paediatrics and the role of nuclear medicine. Do they differ from those in adults?". Hell J Nucl Med. 16 (1): 2–8. doi:10.1967/s002449910065 (inactive 2020-09-19). PMID 23529387.CS1 maint: DOI inactive as of September 2020 (link)
- Hazzazi MA, Alzeer I, Tamimi W, Al Atawi M, Al Alwan I (2013). "Clinical presentation and etiology of osteomalacia/rickets in adolescents". Saudi Journal of Kidney Diseases and Transplantation. 24 (5): 938–41. doi:10.4103/1319-2442.118087. PMID 24029258.
- von Moos, R. Strasser, F. Gillessen, S. Zaugg, K. (2008). Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Supportive Care in Cancer. 16(10): 1105-1115.
- Mercadante, S. (1997). Malignant bone pain: Pathophysiology and treatment. Pain. 69(1-2):1-18.
- Furuse, S. Kawamata, T. Yamamoto, J. Niiyama, Y. Omote, K. Watanabe, M. Namiki, A.(2009). Reduction of Bone Cancer Pain by Activation of Spinal Cannabinoid Receptor 1 and Its Expression in the Superficial Dorsal Horn of the Spinal Cord in a Murine Model of Bone Cancer Pain. Anesthesiology. 111: 173–86.